about
Myocardial injury in HIV-associated thrombotic thrombocytopenic purpura (TTP).The impact of HIV-associated anaemia on the incidence of red blood cell transfusion: implications for blood services in HIV-endemic countries.Cranial plasmacytoma: a case series and review of the literature.Clinical experience with pericardiocentesis and extended drainage in a population with a high prevalence of HIV.Prognosis and treatment of Waldenström's macroglobulinemia.Factors affecting the current status of transfusion medicine education in South Africa.Determining the outcomes for clinicians completing a postgraduate diploma in transfusion medicine.The difference in scope of practice between a specialist in transfusion medicine and the clinician who deals with transfusion on an ad hoc basis.Recommendations for the management of sickle cell disease in South Africa.Pica Practices among Apparently Healthy Women and Their Young Children in Ghana.Cucurbitacin B inhibits growth, arrests the cell cycle, and potentiates antiproliferative efficacy of cisplatin in cutaneous squamous cell carcinoma cell lines.Concomitant HIV infection in newly diagnosed multiple myeloma patients is hard to recognise and should be tested for routinely in areas of high endemicity.Treatment Outcomes in CML Patients Treated With Tyrosine Kinase Inhibitors at a Tertiary Teaching Hospital in South Africa.Chakalaka-induced vasodilatation in patients with chronic myeloid leukaemia on tyrosine kinase inhibitors.Chronic myeloid leukaemia and human immunodeficiency virus (HIV) infection.The silhouette sign revisited.Plasma cell leukaemia and HIV co-infection: profile of patients and experience at Universitas Academic Hospital in Bloemfontein, South Africa.Exchange transfusion as a life-saving intervention in three patients with different haematological malignancies with severe hyperleukocytosis where leukapheresis was not available.Guidelines for the treatment of myelodysplastic syndromes (MDS) in South Africa.Transfusion education and practice in South Africa.Chronic myeloid leukaemia in South Africa.Sickle cell disease in a carrier with pyruvate kinase deficiency.Challenges in transfusion medicine recruitment and training--a solution.Nilotinib dose-optimization in newly diagnosed chronic myeloid leukaemia in chronic phase: final results from ENESTxtnd.The future of transfusion medicine in under resourced countries.Biography: Professor Vernon J. Louw.The long-term effects of training interventions on transfusion practice: a follow-up audit of red cell concentrate utilisation at Kimberley Hospital, South Africa.Patients' recall and perceptions regarding consent to blood transfusion at Universitas Academic Hospital, Bloemfontein, South Africa.An audit of the use of platelet transfusions at Universitas Academic Hospital, Bloemfontein, South Africa.The management of tuberculous pericardial effusion: experience in 233 consecutive patientsThe determinants and impact of diagnostic delay in lymphoma in a TB and HIV endemic settingTwelve-lead electrocardiography in tuberculous pericarditisExperience with adjunctive corticosteroids in managing tuberculous pericarditisPica and food craving in adult patients with iron deficiency in Bloemfontein, South AfricaEffect of cytochrome P450 3A4 inducers on the pharmacokinetic, pharmacodynamic and safety profiles of bortezomib in patients with multiple myeloma or non-Hodgkin's lymphomaThe role of the state in establishing a public cord blood stem cell bankMassive megakaryocyte clustering in triple-negative primary myelofibrosis associated with an unusual cytogenetic aberrationCarcinoid tumour
P50
Q33389227-7890BD81-240B-401D-B20B-E91EAADA58F2Q35915467-749DABC3-3D90-4133-A212-6DEE67152182Q36609270-F854EBAD-477C-41C4-BF67-C15F29B73421Q36817360-10C07B57-EE76-4331-870D-F1723E2D6A78Q37684303-CF56835C-57B4-4398-ABC4-500A29A2F4ECQ38112515-BAC9024A-ABFC-4AE9-87EF-57AD16DCEB91Q38279859-489AA027-DD42-473E-AA59-ADE5FA4C0F9FQ38279860-0C6B39C0-51A2-4B86-8468-4AEB28C04944Q38440370-064AC75B-BCFF-43EA-B51C-97F94B2805CBQ38820250-421367E6-650C-4624-A7DB-1B60B472F7EFQ39674848-7116F27C-CE24-4A5D-87C4-BDC5D64E9C54Q40065098-A55B93C3-645C-4207-BDBA-1B182EAD3BADQ40415077-027887F1-47AC-45FC-99EC-94FD360BC804Q43066418-B82E5E16-3222-4369-9861-33BF401A939BQ45358123-E18A81A0-F28A-472B-9710-D55E36EFA52EQ46144867-433A1F74-5BAC-45BD-9070-699A9BEDD043Q46162763-5B398C23-7112-4DB8-AE81-9CDF142DA291Q46178806-E21A0608-067D-4C05-A5B6-A3B2279A4248Q46196438-0AB4F098-17D6-45BE-9753-389DF7E1C681Q46210075-F5637D07-D691-42C1-88E7-541EE512C01CQ46214120-2F0A4F8C-4B9D-4B52-AF30-66DAE700CB68Q46214476-EC37619B-D66E-43A0-B1DA-5FB0C1F74CB4Q46570778-0BA97988-CBAA-4882-9870-C202A0B20E7EQ47149685-2C24E61B-0D65-4FC3-937F-F942439DED1BQ48057814-106E8126-6E7B-4715-8C5F-11A4DB06A85EQ48057816-EB75C622-F1B8-44D3-A8C4-A37E0818E913Q50456166-AEEBF60D-BAA2-4604-8165-0D59B152E760Q53815819-7E3F6BBF-E891-418C-BF3C-24F5E2919B36Q53815824-2D6C32A9-FDBE-4243-8F20-580EAC9D99F7Q56786480-C4D0FC95-3CCA-4428-96FB-7049CD0E8F5EQ64087281-64D10B0F-C630-4056-8FD1-DB173A817AADQ74181395-67558B71-2DF6-4C68-B377-7C626DE3968AQ79372782-7F8A5B6A-AB62-401F-9285-A2421C9FBA20Q80634975-E4788B5A-0A18-4E4E-9731-93721B7D61DEQ82526829-68B7F7F1-5965-4725-A035-C8014DFAE1CEQ84203412-2B971B48-4D10-4CC8-AADC-66AB5649528CQ92576839-65D1FD4B-D433-4BD4-9048-2DBEC1854336Q93913822-5CF27EA2-A6C1-4819-8DB7-F97D10A1BCFF
P50
description
researcher
@en
wetenschapper
@nl
name
V J Louw
@en
V J Louw
@nl
type
label
V J Louw
@en
V J Louw
@nl
prefLabel
V J Louw
@en
V J Louw
@nl
P106
P31
P496
0000-0002-2885-3342